Transthyretin Decrease in Plasma of MCI and AD Patients: Investigation of Mechanisms for Disease Modulation

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|9|8|881-889

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.9, Iss.8, 2012-10, pp. : 881-889

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels

By  

Current Alzheimer Research, Vol. 7, Iss. 1, 2010-02 ,pp. : 15-20

Bentham Science Publishers

Access to resources Recommend Favorite

Allocentric to Egocentric Spatial Switching: Impairment in aMCI and Alzheimer's Disease Patients?

By  

Current Alzheimer Research, Vol. 15, Iss. 3, 2018-01 ,pp. : 229-236

Bentham Science Publishers

Access to resources Recommend Favorite

Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage

By  

Current Alzheimer Research, Vol. 13, Iss. 2, 2016-02 ,pp. : 112-122

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Spatial Cognition in Normal Aging, MCI and AD

By  

Current Alzheimer Research, Vol. 15, Iss. 3, 2018-01 ,pp. : 202-204

Bentham Science Publishers

Access to resources Recommend Favorite

Transthyretin familial amyloid polyneuropathy: delineating the individual disease risk to improve management of patients and carriers

By Plantéé-Bordeneuve Violaine   Norgren Nina  

Future Neurology, Vol. 6, Iss. 4, 2011-07 ,pp. : 437-440

Future Medicine

Access to resources Recommend Favorite